Steve Krognes - CFO and Treasurer, Denali Therapeutics Inc

As of February 15, 2022


Steve Krognes Net Worth

  • Net worth is estimated to be at least $46.04M
  • Owns at least 970,221 units of Denali Therapeutics Inc stock
  • Sold an estimated value of $10.72M in the last 5 years at Denali Therapeutics Inc

Steve Krognes Compensation at Denali Therapeutics Inc in 2020

  • Earned a $484,200 salary and a $387 bonus
  • Rewarded $1,364,638 in stock value and options
  • Received a total compensation of $4,266,044

Steve Krognes Trading

  • Largest sale of shares was 50,000 units , worth over $3.57M on January 20, 2021
  • In total has made about 20 transactions over 5 years
  • Usually trades in February, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Steve Krognes Mailing Address

  • Mailing address is 863 Mitten Road, Suite 102 Burlingame CA 94010 CA

Denali Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Ryan J. Watts, Ph.D. 2020 $589,472 $648,419 $2,596,305 $5,456,849 $11,400 $9,302,445
Ryan J. Watts, Ph.D. 2019 $566,800 $311,740 $838,168 $3,252,452 $9,447 $4,978,607
Ryan J. Watts, Ph.D. 2018 $545,000 $524,563 $ $4,914,360 $ $5,983,923
Alexander O. Schuth, M.D. 2020 $449,400 $359,520 $1,364,638 $2,018,444 $11,400 $4,203,402
Alexander O. Schuth, M.D. 2019 $428,000 $171,200 $305,830 $1,558,941 $12,657 $2,476,628
Alexander O. Schuth, M.D. 2018 $400,000 $355,000 $179,673 $2,948,616 $18,500 $3,901,789
Steve E. Krognes 2020 $484,200 $387,362 $1,364,638 $2,018,444 $11,400 $4,266,044
Steve E. Krognes 2019 $470,057 $188,023 $305,830 $1,558,941 $7,834 $2,530,685
Steve E. Krognes 2018 $455,260 $393,682 $179,673 $2,948,616 $24,000 $4,001,231
Carole Ho, M.D. 2020 $457,600 $366,080 $1,382,774 $2,107,493 $11,400 $4,325,347
Carole Ho, M.D. 2019 $440,000 $176,000 $305,830 $1,558,941 $8,800 $2,489,571
Carole Ho, M.D. 2018 $423,124 $371,187 $179,673 $2,948,616 $12,869 $3,935,469
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1714899/000171489921000042/fy20def14aproxy.htm

Denali Therapeutics Inc Insider Trading

  • The most recent transaction was 20,000 units sold on March 25, 2022 by Marc Tessierlavigne worth over $676.58K
  • In the last 5 years, insiders at Denali Therapeutics Inc sold an estimated value of $436.02M and bought an estimated value of $7.95M
  • The most active traders are Alexander Schuth, COO and Secretary,  Ryan Watts, President and CEO,  and Carole Ho, Chief Medical Officer
  • Insider trading is most common in June, with the busiest year in 2021

Denali Therapeutics Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1